tiprankstipranks
Otsuka Holdings Co Ltd (OTSKY)
OTHER OTC:OTSKY
US Market

Otsuka Holdings Co (OTSKY) Stock Price & Analysis

18 Followers

OTSKY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$16.45 - $21.37
Previous Close$20.03
Volume26.00K
Average Volume (3M)27.39K
Market Cap
$21.78B
Enterprise Value$20.11B
Total Cash (Recent Filing)¥489.12B
Total Debt (Recent Filing)¥194.16B
Price to Earnings (P/E)25.1
Beta0.34
Apr 30, 2024
Dividend Yield2.32%
Share Statistics
EPS (TTM)0.83
Shares OutstandingN/A
10 Day Avg. Volume52,250
30 Day Avg. Volume27,394
Standard Deviation0.07
R-Squared0.08
Alpha0.00087
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%0.32%99.68%
0.00%
Insiders
0.32% Other Institutional Investors
99.68% Public Companies and
Individual Investors

OTSKY FAQ

What was Otsuka Holdings Co Ltd’s price range in the past 12 months?
Otsuka Holdings Co Ltd lowest stock price was $16.45 and its highest was $21.37 in the past 12 months.
    What is Otsuka Holdings Co Ltd’s market cap?
    Currently, no data Available
    When is Otsuka Holdings Co Ltd’s upcoming earnings report date?
    Otsuka Holdings Co Ltd’s upcoming earnings report date is Apr 30, 2024 which is 6 days ago.
      How were Otsuka Holdings Co Ltd’s earnings last quarter?
      Otsuka Holdings Co Ltd released its earnings results on Feb 14, 2024. The company reported -$0.042 earnings per share for the quarter, missing the consensus estimate of $0.218 by -$0.26.
        Is Otsuka Holdings Co Ltd overvalued?
        According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Otsuka Holdings Co Ltd pay dividends?
          Otsuka Holdings Co Ltd pays a Semiannually dividend of $0.15 which represents an annual dividend yield of 2.32%. See more information on Otsuka Holdings Co Ltd dividends here
            What is Otsuka Holdings Co Ltd’s EPS estimate?
            Otsuka Holdings Co Ltd’s EPS estimate is $0.4.
              How many shares outstanding does Otsuka Holdings Co Ltd have?
              Otsuka Holdings Co Ltd has 1,115,672,000 shares outstanding.
                What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?
                Otsuka Holdings Co Ltd reported an EPS of -$0.042 in its last earnings report, missing expectations of $0.218. Following the earnings report the stock price went up 1.405%.
                  Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?
                  Currently, no hedge funds are holding shares in OTSKY
                  ---

                  Otsuka Holdings Co Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  23.79%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  5.33%
                  Trailing 12-Months
                  Asset Growth
                  1.39%
                  Trailing 12-Months

                  Company Description

                  Otsuka Holdings Co Ltd

                  Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Bristol-Myers Squibb
                  AstraZeneca
                  Sanofi
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis